Skip to main content

Onconase FDA Approval Status

FDA Approved: No
Brand name: Onconase
Generic name: ranpirnase
Company: Alfacell Corporation
Treatment for: Malignant Pleural Mesothelioma

Onconase (ranpirnase) is a ribonuclease enzyme in development for the treatment of unresectable malignant mesothelioma.

Development timeline for Onconase

Jan 28, 2009Alfacell Provides Onconase NDA Submission Update - Jan 28, 2009
Dec  8, 2008Alfacell Provides Onconase NDA Submission Update - Dec 8, 2008
Oct  2, 2006Alfacell Completes Non-Clinical Section of Rolling NDA for Lead Anticancer Drug Onconase

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.